Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009

Pediatric Blood and Cancer

Volumn 59, Issue 7, 2012, Pages 1234-1238

  Aka, Peter ^a   Kawira, Esther ^b   Masalu, Nestory ^c   Emmanuel, Benjamin ^a   Brubaker, Glen ^d   Magatti, Josiah ^b   Mbulaiteye, Sam M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Shirati Health Education and Development Foundation ^*  (Tanzania)

^c Bugando Medical Center   (Tanzania)

^d Interchurch Medical Assistance   (United States)

Author keywords

Burkitt lymphoma; Epidemiology; Epstein Bar virus; Malaria; Tanzania

Indexed keywords

ABDOMINAL TUMOR; ADOLESCENT; AGE; ARTICLE; BURKITT LYMPHOMA; CHILD; CONTROLLED STUDY; FACE TUMOR; FEMALE; HEAD TUMOR; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX; TANZANIA; TUMOR LOCALIZATION;

ADOLESCENT; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; RISK FACTORS; TANZANIA;

EID: 84867340711     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24194     Document Type: Article

References (33)

1. Carneiro PM, Kalokola FM, Kaaya EE. Paediatric malignancies in Tanzania. East Afr Med J 1998; 75: 533- 535.
2. Mgaya EM, Kitinya JN. Histopathology of malignant tumours of childhood in Tanzania. East Afr Med J 2000; 77: 435- 439.
3. Parkin DM, Sitas F, Chirenje M, et al. Part I: Cancer in Indigenous Africans-Burden, distribution, and trends. Lancet Oncol 2008; 9: 683- 692.
4. Morrow RH, Jr. Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt's lymphoma. IARC Sci Publ 1985; 60: 177- 186.
5. de-The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274: 756- 761.
6. Carpenter LM, Newton R, Casabonne D, et al. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: A case-control study in Uganda. Int J Cancer 2008; 122: 1319- 1323.
7. de-The G. Epstein-Barr virus and Burkitt's lymphoma worldwide: The causal relationship revisited. IARC Sci Publ 1985; 60: 165- 176.
8. Rainey JJ, Mwanda WO, Wairiumu P, et al. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Int Health 2007; 12: 936- 943.
9. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995; 59: 387- 405.
10. Geser A, de The G, Lenoir G, et al. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 1982; 29: 397- 400.
11. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516- 1526.
12. Rogerson SJ, Wijesinghe RS, Meshnick SR. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria Lancet Infect Dis 2010; 10: 51- 59.
13. Chene A, Donati D, Orem J, et al. Endemic Burkitt's lymphoma as a polymicrobial disease: New insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. Semin Cancer Biol 2009; 19: 411- 420.
14. Carpenter D, Rooth I, Farnert A, et al. Genetics of susceptibility to malaria related phenotypes. Infect Genet Evol 2009; 9: 97- 103.
15. Baik S, Mbaziira M, Williams M, et al. A case-control study of Burkitt lymphoma in East Africa: Are local health facilities an appropriate source of representative controls? Infect Agent Cancer 2012; 7: 5.
16. Geser A, Brubaker G. A preliminary report of epidemiological studies of Burkitt's lymphoma, Epstein-Barr virus infection and malaria in North Mara, Tanzania. IARC Sci Publ 1985; 60: 205- 215.
17. Orroth KK, Korenromp EL, White RG, et al. Higher risk behaviour and rates of sexually transmitted diseases in Mwanza compared to Uganda may help explain HIV prevention trial outcomes. AIDS 2003; 17: 2653- 2660.
18. Wabinga HR, Parkin DM, Wabwire-Mangen F, et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000; 82: 1585- 1592.
19. Ogwang MD, Bhatia K, Biggar RJ, et al. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008; 123: 2658- 2663.
20. Geser A, Brubaker G, Draper CC. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am J Epidemiol 1989; 129: 740- 752.
21. O'Meara WP, Mangeni JN, Steketee R, et al. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010; 10: 545- 555.
22. Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673- 696, v.
23. Mutalima N, Molyneux E, Jaffe H, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: Results from a case-control study. PLoS ONE 2008; 3: e2505.
24. Newton R, Ziegler J, Beral V, et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 2001; 92: 622- 627.
25. Mutalima N, Molyneux EM, Johnston WT, et al. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi-Preliminary findings. Infect Agent Cancer 2010; 5: 5.
26. Parkin DM, Garcia-Giannoli H, Raphael M, et al. Non-Hodgkin lymphoma in Uganda: A case-control study. AIDS 2000; 14: 2929- 2936.
27. Global report: UNAIDS report on the global AIDS epidemic 2010.
28. Mbulaiteye SM, Talisuna AO, Ogwang MD, et al. African Burkitt's lymphoma: Could collaboration with HIV-1 and malaria programmes reduce the high mortality rate? Lancet 2010; 375: 1661- 1663.
29. Emmanuel B, Kawira E, Ogwang MD, et al. African Burkitt lymphoma: Age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg 2011; 84: 397- 401.
30. Mbulaiteye SM, Biggar RJ, Bhatia K, et al. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer 2009; 53: 366- 370.
31. Guech-Ongey M, Simard EP, Anderson WF, et al. AIDS-related Burkitt lymphoma in the United States: What do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood 2010; 116: 5600- 5604.
32. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32- 38.
33. Rose G. Sick individuals and sick populations. 1985. Bull World Health Organ 2001; 79: 990- 996.